These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 11082844)

  • 41. Rigid analogs of DMPP as probes for the nicotinic receptors.
    Guandalini L; Martini E; Martelli C; Romanelli MN; Varani K
    Farmaco; 2005 Feb; 60(2):99-104. PubMed ID: 15752468
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cholinergic channel activators: novel opportunities for the treatment of CNS disorders.
    Sullivan JP; Decker MW; Donnelly-Roberts D; Brioni JD; Bannon AW; Holladay MW; Anderson DJ; Briggs CA; Williams M; Arneric SP
    Proc West Pharmacol Soc; 1995; 38():127-30. PubMed ID: 7480004
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel alpha-7 nicotinic acetylcholine receptor agonists containing a urea moiety: identification and characterization of the potent, selective, and orally efficacious agonist 1-[6-(4-fluorophenyl)pyridin-3-yl]-3-(4-piperidin-1-ylbutyl) urea (SEN34625/WYE-103914).
    Ghiron C; Haydar SN; Aschmies S; Bothmann H; Castaldo C; Cocconcelli G; Comery TA; Di L; Dunlop J; Lock T; Kramer A; Kowal D; Jow F; Grauer S; Harrison B; La Rosa S; Maccari L; Marquis KL; Micco I; Nencini A; Quinn J; Robichaud AJ; Roncarati R; Scali C; Terstappen GC; Turlizzi E; Valacchi M; Varrone M; Zanaletti R; Zanelli U
    J Med Chem; 2010 Jun; 53(11):4379-89. PubMed ID: 20465311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel acetylcholine and carbamoylcholine analogues: development of a functionally selective alpha4beta2 nicotinic acetylcholine receptor agonist.
    Hansen CP; Jensen AA; Christensen JK; Balle T; Liljefors T; Frølund B
    J Med Chem; 2008 Dec; 51(23):7380-95. PubMed ID: 18989912
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery of potent α1L-adrenoceptor agonists: Design and synthesis of bicyclic derivatives.
    Suzuki S; Okano T; Horiuchi R; Hareyama N; Amikura K; Yamamoto N; Yoshizawa Y; Yagi M; Serizawa K; Hayashi R
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3368-72. PubMed ID: 26087939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bioisosteric replacement strategy for the synthesis of 1-azacyclic compounds with high affinity for the central nicotinic cholinergic receptors.
    Olesen PH; Tønder JE; Hansen JB; Hansen HC; Rimvall K
    Bioorg Med Chem; 2000 Jun; 8(6):1443-50. PubMed ID: 10896121
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ibogaine analogues. Synthesis and preliminary pharmacological evaluation of 7-heteroaryl-2-azabicyclo[2.2.2]oct-7-enes.
    Passarella D; Favia R; Giardini A; Lesma G; Martinelli M; Silvani A; Danieli B; Efange SM; Mash DC
    Bioorg Med Chem; 2003 Mar; 11(6):1007-14. PubMed ID: 12614886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Total synthesis of neooxazolomycin.
    Onyango EO; Tsurumoto J; Imai N; Takahashi K; Ishihara J; Hatakeyama S
    Angew Chem Int Ed Engl; 2007; 46(35):6703-5. PubMed ID: 17663493
    [No Abstract]   [Full Text] [Related]  

  • 49. The combinatorial synthesis of bicyclic privileged structures or privileged substructures.
    Horton DA; Bourne GT; Smythe ML
    Chem Rev; 2003 Mar; 103(3):893-930. PubMed ID: 12630855
    [No Abstract]   [Full Text] [Related]  

  • 50. Formal synthesis of (+)-madindoline A, a potent IL-6 inhibitor, utilizing enzymatic discrimination of quaternary carbon.
    Shimizu K; Tomita M; Fuhshuku K; Sugai T; Shoji M
    Nat Prod Commun; 2013 Jul; 8(7):897-901. PubMed ID: 23980418
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for neuronal nicotinic acetylcholine receptors.
    Murineddu G; Murruzzu C; Curzu MM; Chelucci G; Gotti C; Gaimarri A; Legnani L; Toma L; Pinna GA
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6147-50. PubMed ID: 18938077
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epibatidine structure-activity relationships.
    Carroll FI
    Bioorg Med Chem Lett; 2004 Apr; 14(8):1889-96. PubMed ID: 15050621
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthesis and electrophysiological studies of a novel epibatidine analogue.
    Spang JE; Patt JT; Bertrand S; Bertrand D; Westera G; Schubiger PA
    J Recept Signal Transduct Res; 1999; 19(1-4):521-31. PubMed ID: 10071782
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis of a fluorine-18 labeled derivative of epibatidine for in vivo nicotinic acetylcholine receptor PET imaging.
    Dolci L; Dolle F; Valette H; Vaufrey F; Fuseau C; Bottlaender M; Crouzel C
    Bioorg Med Chem; 1999 Mar; 7(3):467-79. PubMed ID: 10220033
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An alternative improved synthesis of (-)-norferruginine, a potent nAChR agonist.
    Wegge T; Schwarz S; Seitz G
    Pharmazie; 2000 Oct; 55(10):779-80. PubMed ID: 11082844
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.